Article
A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT.
Pharmacogenetics and genomics - 1 Nov 2012
Brown Chad C, Havener Tammy M, Medina Marisa W, Auman J Todd, Mangravite Lara M, Krauss Ronald M, McLeod Howard L, Motsinger-Reif Alison A
Abstract excerpt
OBJECTIVE: Recently, lymphoblastoid cell lines (LCLs) have emerged as an innovative model system for mapping gene variants that predict the dose response to chemotherapy drugs. METHODS: In the current study, this strategy was expanded to the in-vitro genome-wide association approach, using 516 LCLs derived from a White cohort to assess the cytotoxic response to temozolomide. RESULTS: Genome-wide association...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
